XTX Topco’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.28M Buy
400,887
+170,781
+74% +$835K 0.03% 992
2026
Q1
$987K Buy
230,106
+195,322
+562% +$1.09M 0.02% 1428
2025
Q4
$312K Sell
34,784
-72,156
-67% -$447K 0.01% 2031
2025
Q3
$396K Sell
106,940
-8,781
-8% -$23.9K 0.02% 1268
2025
Q2
$226K Buy
115,721
+60,157
+108% +$125K 0.01% 1628
2025
Q1
$97.8K Buy
55,564
+44,979
+425% +$102K 0.01% 1877
2024
Q4
$28.2K Sell
10,585
-121,444
-92% -$313K ﹤0.01% 1989
2024
Q3
$302K Buy
+132,029
New +$403K 0.02% 1179
2024
Q2
Sell
-174,490
Closed -$635K 2295
2024
Q1
$635K Sell
174,490
-69,750
-29% -$134K 0.09% 348
2023
Q4
$369K Buy
244,240
+217,666
+819% +$280K 0.08% 467
2023
Q3
$35.6K Sell
26,574
-6,979
-21% -$11.6K 0.01% 1317
2023
Q2
$60.4K Sell
33,553
-16,021
-32% -$27.2K 0.01% 1218
2023
Q1
$82.3K Sell
49,574
-328
-0.7% -$665 0.02% 1119
2022
Q4
$95.8K Buy
+49,902
New +$101K 0.02% 1006
2022
Q3
Sell
-56,307
Closed -$182K 1295
2022
Q2
$182K Buy
+56,307
New +$246K 0.07% 490

Other funds holding NUVB

XTX Topco's NUVB Position: Q2 2026 in Review

XTX Topco increased its Nuvation Bio (NUVB) stake by 74% in Q2 2026, buying an estimated $835K and bringing the position to 400,887 shares worth $2.28M. The position accounts for 0.03% of the portfolio, ranked #992.

XTX Topco first reported a position in NUVB in Q2 2022 and has held it in 15 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • XTX Topco held 400,887 shares of Nuvation Bio worth $2.28M as of Q2 2026.
  • XTX Topco bought 170,781 Nuvation Bio shares in Q2 2026, an estimated $835K.
  • Nuvation Bio made up 0.03% of XTX Topco's portfolio in Q2 2026, its #992 holding.
  • XTX Topco first reported a position in Nuvation Bio in Q2 2022 and has held it in 15 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.